These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer Patients. Nikolaou VA; Apalla Z; Carrera C; Fattore D; Sollena P; Riganti J; Segura S; Freites-Martinez A; Lallas K; Romano MC; Oikonomou C; Starace M; Dimopoulos MA; Kyrgidis A; Lazaridou E; Giavedoni P; Annunziata MC; Peris K; Echeverría M; Lopez-Tujillo E; Syrigos K; Papageorgiou C; Podlipnik S; Fabbrocini G; Torre AC; Kemanetzi C; Villa-Crespo L; Lallas A; Stratigos AJ; Sibaud V Br J Dermatol; 2022 Dec; 187(6):962-969. PubMed ID: 35861701 [TBL] [Abstract][Full Text] [Related]
6. Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management. Coleman E; Ko C; Dai F; Tomayko MM; Kluger H; Leventhal JS J Am Acad Dermatol; 2019 Apr; 80(4):990-997. PubMed ID: 30399387 [TBL] [Abstract][Full Text] [Related]
7. A case of severe nivolumab-induced lichen planus pemphigoides in a child with metastatic spitzoid melanoma. Mueller KA; Cordisco MR; Scott GA; Plovanich ME Pediatr Dermatol; 2023 Jan; 40(1):154-156. PubMed ID: 35882548 [TBL] [Abstract][Full Text] [Related]
8. Dermatologic toxicities to immune checkpoint inhibitor therapy: A review of histopathologic features. Ellis SR; Vierra AT; Millsop JW; Lacouture ME; Kiuru M J Am Acad Dermatol; 2020 Oct; 83(4):1130-1143. PubMed ID: 32360716 [TBL] [Abstract][Full Text] [Related]
10. Case Series of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis With Nivolumab and Nivolumab/ Ipilimumab Combination Therapy in Metastatic Melanoma. Lee O; Masood M; Nutan F J Drugs Dermatol; 2022 May; 21(5):529-530. PubMed ID: 35533039 [TBL] [Abstract][Full Text] [Related]
11. Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma. Marques-Piubelli ML; Tetzlaff MT; Nagarajan P; Duke TC; Glitza Oliva IC; Ledesma DA; Aung PP; Torres-Cabala CA; Wistuba II; Prieto VG; Nelson KC; Curry JL J Cutan Pathol; 2020 Oct; 47(10):954-959. PubMed ID: 32394425 [TBL] [Abstract][Full Text] [Related]
12. Lichenoid dermatitis following PD-1 inhibitor-induced toxic epidermal necrolysis: a case report and literature review. Zhang L; Wang L; Cheng Q; Lei X; Wu J; Chen N Immunotherapy; 2023 Oct; 15(15):1249-1256. PubMed ID: 37585673 [TBL] [Abstract][Full Text] [Related]
13. Lichen planus pemphigoides: A unique form of bullous and lichenoid eruptions secondary to nivolumab. Shah RR; Bhate C; Hernandez A; Ho CH Dermatol Ther; 2022 May; 35(5):e15432. PubMed ID: 35266258 [TBL] [Abstract][Full Text] [Related]
14. A retrospective observational study on cutaneous adverse events induced by immune checkpoint inhibitors. Medri M; Savoia F; Foca F; Miserocchi A; Quaglino P; Rubatto M; Gullo G; Nardini C; Panasiti V; DE Tursi M; DI Marino P; Brancaccio G; Giunta EF; Napolitano S; Cinotti E; Brusasco M; Stanganelli I; Ital J Dermatol Venerol; 2023 Dec; 158(6):437-444. PubMed ID: 38015482 [TBL] [Abstract][Full Text] [Related]
15. Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Pharmacovigilance Study. Le TK; Brown I; Goldberg R; Taylor MT; Deng J; Parthasarathy V; Bordeaux ZA; Alphonse MP; Kwatra MM; Naranbhai V; Gusev A; Alhariri J; LeBoeuf NR; Reynolds KL; Cappelli LC; Naidoo J; Brahmer JR; Kang S; Semenov YR; Kwatra SG J Invest Dermatol; 2022 Nov; 142(11):2896-2908.e4. PubMed ID: 35605659 [TBL] [Abstract][Full Text] [Related]
16. Narrowband ultraviolet B therapy for refractory immune-related lichenoid dermatitis on PD-1 therapy: a case report. Esfahani K; Henderson Berg MH; Zargham H; Billick R; Pehr K; Redpath M; Roshdy O; Miller WH J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33771890 [TBL] [Abstract][Full Text] [Related]
20. Oral lichenoid reaction showing multiple ulcers associated with anti-programmed death cell receptor-1 treatment: A report of two cases and published work review. Obara K; Masuzawa M; Amoh Y J Dermatol; 2018 May; 45(5):587-591. PubMed ID: 29352490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]